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ABSTRACT
Purpose: To determine whether there was a change
in the resistance pattern of bacteria isolated from cases
of conjunctivitis following the introduction of over-the-
counter availability of chloramphenicol in 2005.
Design and setting: Retrospective review of
laboratory records for adult patients with suspected
bacterial conjunctivitis between 2001 and 2012
attending the Royal Liverpool University Hospital.
Participants: Patients with suspected bacterial
conjunctivitis. Organisms were identified by standard
laboratory methods. Scanty growth and normal flora
were considered as a negative result. For positive
results, susceptibility testing was undertaken as per
British Society for Antimicrobial Chemotherapy
guidelines.
Main outcome measures: Prevalence of groups of
bacteria associated with acute conjunctivitis and their
resistance to chloramphenicol, ciprofloxacin,
gentamicin, and methicillin.
Results: A total of 8209 conjunctival swabs were
reviewed; 1300 (15.8%) were considered positive, of
which 977 (75.2%) and 323 (24.8%) bacteria were
identified as Gram positive and Gram negative,
respectively. Staphylococcus aureus was the most
prevalent organism identified. Resistance of all
bacterial isolates to chloramphenicol was 8.4% varying
from 3.0% to 16.4% while that for ciprofloxacin and
gentamicin was 16.4% and 14.0%, respectively.
Methicillin resistance among S. aureus was 8.3%.
Conclusion: Resistance to chloramphenicol has
remained stable since being made available over the
counter. Among Gram-positive bacteria, the most
prevalent causative agent of bacterial conjunctivitis,
chloramphenicol sensitivity remains high.
BACKGROUND
Acute infective conjunctivitis is an inflam-
mation of the conjunctiva secondary to a
bacterial or viral infection. It is a common
condition with bacterial conjunctivitis hav-
ing an estimated incidence of 135 per
10 000 in the USA.1 In severe cases, it may
result in conjunctival scarring and
secondary damage to the ocular surface. A
meta-analysis2 concluded that while bacte-
rial conjunctivitis is often self-limiting, anti-
microbial use is associated with improved
rates of clinical and microbiological
remission. Inappropriate use of antimicro-
bials, however, is associated with increased
bacterial resistance, and in recent years
there has been a global drive to reduce the
prescribing of antimicrobials. While pre-
scribing chloramphenicol for conjunctivitis
among general practitioners in the UK has
fallen,3 its use has increased several fold
since 2005, when it became the first antibi-
otic available over the counter.4 Surveillance
of causative organisms and resistance sus-
ceptibility patterns are important in guiding
antimicrobial selection. While large studies
in the USA5 6 have investigated trends in
bacterial resistance to antimicrobials over
the last decade, these have limited applica-
tion in the UK as chloramphenicol, an anti-
biotic very commonly used in the UK, is not
used in the USA due to the rare purported
association between topically administered
chloramphenicol and aplastic anaemia. A
Key messages
What is already known about this subject?
Bacterial conjunctivitis is common and often treated
empirically with topical antimicrobials. Inappropriate
use of antimicrobials has led to increased bacterial
resistance.
What are the new findings?
Among Gram-positive bacteria, the most prevalent
cause of bacterial conjunctivitis, chloramphenicol
sensitivity remains high.
How might these results change the focus of
research or clinical practice?
Topical chloramphenicol remains a suitable first-line
treatment for bacterial conjunctivitis.
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review of its use in the UK concluded that topical
chloramphenicol was not a significant risk factor for
inducing dose-related bone marrow toxicity.7 To deter-
mine resistance patterns of bacteria isolated from cases
of conjunctivitis to commonly prescribed antimicro-
bials, laboratory reports of patients presenting with sus-
pected acute conjunctivitis were reviewed. The
prevalence of the organisms causing acute bacterial
conjunctivitis and their sensitivities to chloramphenicol
and other commonly used topical antimicrobials were
examined between 2001 and 2012.
METHODS
Laboratory records for all bacterial swabs taken from
adult patients with suspected bacterial conjunctivitis
presenting to the Royal Liverpool University Hospital,
UK, between 2001 and 2012 were reviewed.
Conjunctival samples were collected using cotton
swabs from the inferior conjunctival fornix as per local
protocol. Samples were inoculated onto chocolate agar,
Columbia agar with 5% horse blood and MacConkey
agar plates, and placed in a 5% CO2 incubator at
37 or in air at 37 (MacConkey agar plate). Plates were
examined after 24 and 48 hours of incubation for the
presence of pathogens associated with
conjunctivitis. Organisms were identified by standard
laboratory methods. A negative result was defined as
either a scanty growth of bacteria or those that were
considered as part of the ‘normal conjunctiva flora’
such as coagulase-negative staphylococci, diphtheroids
and alpha-haemolytic streptococci. Because of the diffi-
culty in distinguishing clinically between bacterial and
viral conjunctivitis, samples were also often taken for
viruses, in particular adenovirus and herpes simplex
virus. Samples for viruses were analysed by real-time
PCR.8 Data for viral isolates were only available from
2006 onwards.
Susceptibility testing was carried out as per British
Society for Antimicrobial Chemotherapy (BSAC) guide-
lines,9 and BSAC templates were used to interpret zone
inhibition diameters for the following antimicrobials:
chloramphenicol, ciprofloxacin and gentamicin.
ANALYSIS
The data are time series and are analysed using linear
regression models. We investigated for a possible
cycling changes in data via a polynomial component of
second, third or fourth order. The order was chosen to
maximize the adjusted coefficient of determination.
The statistical significance of trend and cycles was
judged at level 0.05.
RESULTS
A total of 8209 conjunctival swab results were reviewed,
of which 1300 (15.8%) were considered bacterial cul-
ture positive. The isolation rate by year ranged from
9.8% to 25.2%, and 977 (75.2%) and 323 (24.8%) of
bacterial isolates were identified as Gram-positive and
Gram-negative organisms, respectively (table 1). All
organisms isolated have been listed in box 1. Between
2006 and 2011, 3293 viral conjunctival samples were
collected. An adenovirus was identified in 707 of these,
and 21 (2.97%) of which were also bacterial culture
positive.
In bacterial culture-positive samples, resistance to
chloramphenicol varied from 3.0% to 16.4% (table 1)
and was predominantly among Gram-negative
organisms. There was no significant change in resis-
tance to chloramphenicol over the study period; in
particular, there was no change after 2005. Resistance
to ciprofloxacin and gentamicin over the period
of 2001–2012 was found in 16.4% and 14.0% of iso-
lates, respectively, predominantly among Gram-posi-
tive organisms (80.1% and 69.2%). There was no
Table 1 Bacterial isolates from adults with suspected bacterial conjunctivitis attending Royal Liverpool University Hospital
(2001–2012) and their resistance to chloramphenicol
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Positive isolates 115 152 135 161 110 85 90 66 86 84 100 116
All isolates resistant to
chloramphenicol (%)
12
(10.4)
7
(4.6)
9
(6.7)
18
(11.2)
18
(16.4)
9
(10.6)
5
(5.6)
2
(3.0)
5
(5.8)
5
(6.0)
14
(14.0)
5
(4.3)
No. of Gram-positive
isolates (%)
95
(82.6)
105
(69.1)
96
(71.1)
101
(62.7)
75
(68.2)
70
(82.4)
70
(77.8)
59
(89.4)
79
(91.9)
66
(78.6)
70
(70.0)
91
(78.4)
Gram-positive isolates
resistant to chloramphenicol
(%)
6
(6.32)
1
(1.0)
3
(3.1)
3
(3.0)
6
(8.0)
1
(1.4)
3
(4.2)
0
(0)
2
(2.5)
0
(0)
1
(1.4)
2
(2.2)
No. of of Gram- negative
isolates (%)
20
(17.4)
47
(30.9)
39
(28.9)
60
(37.3)
35
(31.8)
15
(17.7)
20
(22.2)
7
(10.6)
7
(8.1)
18
(21.4)
30
(30.0)
25
(21.6)
Gram-negative isolates
resistant to chloramphenicol
(%)
6
(30.0)
6
(12.8)
6
(15.4)
15
(25.0)
12
(34.3)
8
(53.3)
2
(10.0)
2
(28.6)
3
(42.9)
5
(27.8)
13
(43.3)
3
(12.0)
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significant association between antimicrobial resistance
and isolation rate for each year under study
(p=0.58). There was a significant reduction in methicil-
lin resistance among Staphylococcus aureus isolates
(mean 8.3%, minimum 1.3%, maximum 13.4%,
p=0.038) over the 12-year period (figure 1).
DISCUSSION
Acute infective conjunctivitis is a common
condition. Although cases of viral and bacterial con-
junctivitis have some clinically distinguishing features,
it is not always easy to differentiate them. It is not sur-
prising, therefore, that in the majority of patients stud-
ied, the aetiological agent was an
adenovirus. Although antibacterial agents would not
be indicated in a viral conjunctivitis, because of the
difficulty in distinguishing bacterial and viral causes, it
is not unreasonable to prescribe broad-spectrum anti-
microbials prior to obtaining culture results. It is of
note, therefore, that while prescribing of chloram-
phenicol has fallen, its use has increased due to its
availability over the counter.
In non-ocular infections, over and inappropriate use
of antimicrobials has led to an increase in resistant
organisms10 and the monitoring of antimicrobial
susceptibility and resistance trends is therefore
important. It is of interest, therefore, that over the
study period there was no evidence of an increase in
antimicrobial resistance to commonly prescribed topi-
cal antimicrobials. BSAC breakpoints used for suscepti-
bility testing are derived for systemically delivered
antimicrobials. Caution is, therefore, needed interpret-
ing resistance patterns to topically applied agents.
Although models for topical breakpoints for cases of
keratitis are becoming available,11 there are currently
no interpretative breakpoints for topical antimicrobials
for cases of conjunctivitis.
Based on the systemic breakpoints, chloramphenicol
resistance has remained stable since 2005 when chlor-
amphenicol was made available over the counter.
Among Gram-positive bacteria, chloramphenicol sensi-
tivity remains high. Compared with many topical anti-
bacterial agents, chloramphenicol has excellent
intraocular penetration following topical application.12
Similar to that reported in studies from the USA,5 6 S.
aureus was the most prevalent organism. The preva-
lence of methicillin-resistant S. aureus (MRSA) was,
however, much lower than reported in Japan13 and
USA5 6 and also significantly reduced over the time
period of this study. A reduction of MRSA infections
over this period of time has been demonstrated in
other infections,14and this has been attributed to
enhanced screening and decolonisation of patients
with MRSA in recent years.
A limitation to this study was the low-positive isola-
tion rate. Other papers have shown variable rates of
positive isolates,15and one study had a similar isolation
rate to this paper (15.8%).16 This difference might be
explained by the inclusion of all bacteria isolated in
some studies rather than pathogenic bacteria
only. In addition, our isolation rate might be lower as
bacterial swabs were taken from all patients with sus-
pected conjunctivitis including those with viral
conjunctivitis. Many patients present after they have
already started topical antibiotic treatment, this may
have reduced the positive isolation rate.
Although chloramphenicol remains a useful agent for
bacterial conjunctivitis, in particular for cases of Gram-
positive conjunctivitis, it should not be used if contact
lens related or if Pseudomonas aeruginosa is suspected.17
Despite the ready availability of chloramphenicol
over the counter during the last 7 years, there has been
no increase in chloramphenicol resistance nor a
change in the bacterial spectrum in this cohort of
patients.
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Box 1 Organisms identified from bacterial isolates from
adults with suspected bacterial conjunctivitis attending
Royal Liverpool University Hospital (2001–2012)
Haemolytic streptococcus
Haemophilus influenzae
Moraxella catarrhalis
Morganella morganii
Neisseria gonorrhoeae
Neisseria meningitidis
Pseudomonas sp.
Staphylococcus aureus
Streptococcus pneumoniae
Figure 1 Percentage of Staphylococcus aureus isolated
resistant to methicillin
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